Understanding Biotechnology: From Healthcare to Investment Opportunities

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
csis.org

Understanding the National Security Commission on Emerging Biotechnology Report

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
Foreign Affairs

How America Can Win the Biotech Race

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Houston Chronicle

Is Biotech in a Bubble? The Bear Case Explained

The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not ...
TechCrunch

Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
PharmaTimes

BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development

BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...
Business Wire

Acticor Biotech: ACTIMIS Post-hoc Results on Imaging Stroke Data Using Artificial Intelligence Reinforces Glenzocimab Mode of Action in Stroke Patients

PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of ...